News > First made-in-India intranasal Covid vaccine to be launched on R-Day

First made-in-India intranasal Covid vaccine to be launched on R-Day

Bharat Biotech will launch its intranasal Covid-19 vaccine iNCOVACC on January 26, the company’s CMD Krishna Ella announced. The vaccine manufacturer had already received approval from the Central Drugs Standard Control Organisation (CDSCO) for the nasal vaccine, the first of its kind in India. The company had earlier announced that it would price the intranasal vaccine at Rs 325 per shot for procurement by the government, and 800 per shot for private vaccination centres.